Given the aforementioned important aspects of impaired lipoprotein metabolism beyond LDL, patients with FH should clearly be monitored for HDL-C, TGs, apoA1, and apoB100 plasma levels more frequently. The gene discussed is APOA1; the disease is familial hyperaldosteronism.